Similar effects of a monoamine oxidase inhibitor and a sympathomimetic amine on memory formation

M. Gibbs,K. Ng

DOI: https://doi.org/10.1016/0091-3057(79)90145-X

1979-09-01

Abstract:

What problem does this paper attempt to address?

Psychotomimetic Effects of Different Doses of MK-801 and the Underlying Mechanisms in a Selective Memory Impairment Model

Weiqing Liu,Dong Wang,Wenjuan Hong,Yi Yu,Jinsong Tang,Jicai Wang,Fang Liu,Xiufeng Xu,Liwen Tan,Xiaogang Chen

DOI: https://doi.org/10.1016/j.bbr.2016.10.011

IF: 3.352

2016-01-01

Behavioural Brain Research

Abstract:Although N-methyl-d-aspartate receptor antagonists-induced hypoglutamate rodent models are the most well-established models for preclinical studies of schizophrenia-related deficits, they also evoke a wide spectrum of psychotomimetic side effects. It is significant to increase the specificity of hypoglutamate rodent models. In this study, the recognition memory was evaluated in rats by object recognition test (ORT), sensorimotor gating was evaluated by prepulse inhibition of the startle reflex (PPI), and locomotor activity was measured using open field test. High-performance liquid chromatography was used to measure neurotransmitters content in the medial prefrontal cortex (mPFC) and thalamus (THA). Total Akt and phospho-Akt protein was measured by Western blots. Results showed that 0.3mg/kg of MK-801 was most effective in inducing locomotion. 0.3mg/kg of MK-801 was most effective in decreasing PPI. 0.03mg/kg of MK-801 was most effective in decreasing object memory while not affecting exploration manners in the training session. 0.03mg/kg of MK-801 significantly increased HVA and Glu content in the mPFC. 0.1mg/kg of MK-801 significantly decreased GABA content in the THA. 0.03mg/kg of MK-801 significantly decreased Akt phosphorylation in the mPFC, which was related to the ORT index. In conclusion, a dose of 0.03mg/kg MK-801 can establish a "pure" memory impairment model without contaminations of sensorimotor gating and locomotor activity. MK-801-induced cognitive deficits is associated with increased DA metabolites and glutamate content in the mPFC and decreased GABA content in the THA as well as decrease in Akt phosphorylation in the mPFC.
Evaluation of the role of monoaminergic and nonmonoaminergic systems in the psychotropic effects of morin in mice: an interaction study with receptor blockers

Benneth Ben-Azu,Adegbuyi Oladele Aderibigbe,Abayomi Mayowa Ajayi,Itivere Adrian Omogbiya,Christian Ifeanyi Uruaka,Solomon Umukoro,Ezekiel O. Iwalewa

DOI: https://doi.org/10.1186/s41110-021-00137-5

2021-05-05

Nutrire

Abstract:PurposeTreatment-resistance depression and memory impairment disease, burdened with high levels of serious adverse effects of currently existing antidepressants and memory enhancers, have necessitated the search for alternative agents. Although previous preclinical studies have revealed the antidepressant-like and memory-enhancing potentials of morin, a compound isolated from Morus alba, the neurotransmitter receptor interaction mechanisms of action remain unknown. Hence, the role of monoaminergic and nonmonoaminergic neurotransmitter receptors in the antidepressant-like and memory-enhancing effects in naïve mice were evaluated in this study.MethodsMale Swiss mice were pretreated intraperitoneally with D2-dopaminergic receptor antagonists (haloperidol), 5-HT1- and 5-HT2-receptor antagonist (metergoline), 5-HT synthesis inhibitor (para-chlorophenylalanine), α1-noradrenoceptor antagonist (prazosin), α2-noradrenoceptor antagonist (yohimbine), or cholinergic receptor antagonist (atropine) prior to the administration of morin (100 mg/kg, i.p.) or vehicle (10 mL/kg, i.p.). The memory-enhancing and antidepressant-like effects were then evaluated 30 min later using the open-field test (OFT), Y-maze test (YMT), and forced swim test (FST).ResultsMorin reduced locomotor activity however, it was reversed by metergoline, pCPA, prazosin, yohimbine, haloperidol, and atropine independent of their actions. Morin exhibited antidepressant property in the FST when compared with control (p < 0.05). Metergoline, para-chlorophenylalanine, prazosin, and haloperidol decreased the antidepressant-like activity of morin. Morin showed memory-enhancing effect in the YMT relative to control. Pretreatment with metergoline, para-chlorophenylalanine, or atropine, however, decreased the memory-promoting effect of morin.ConclusionThese findings suggest that the antidepressant-like activity exhibited by morin might be mediated via interactions with 5-HTergic, noradrenergic, and dopaminergic receptors, while the memory-enhancing effect might involve interaction with both 5-HTergic and cholinergic receptors.
Neurochemical mechanisms of a novel Alzheimer's disease therapeutics on improvement of cognition and depressive behavior]

Norifumi Shioda,Yui Yamamoto,Feng Han,Shigeki Moriguchi,Kohji Fukunaga

DOI: https://doi.org/10.1248/yakushi.131.505

2011-01-01

Abstract:Loss of cholinergic neurons and/or dysfunction of the glutamatergic system in the central nervous system cause learning impairment in experimental Alzheimer's (Alz) disease animals and Alz patients. Furthermore, the impaired cholinergic system is likely implicated in depressive behaviors in Alz patients. Neurogenesis persistently occurs in the forebrain subventricular zone (SVZ) and hippocampal subgranular zone (SGZ) in rodent and human brains. Notably, impaired neurogenesis in those regions is implicated not only in memory deficits but also in depressive behaviors. We have recently found that olfactory bulbectomized (OBX) mice reveal memory impairment and depressive behaviors. Using this attractive OBX mice model, we discovered a novel cognitive enhancer, Spiro [imidazo [1,2-a] pyridine-3,2-indan] -2 (3H) -one (ZSET1446/ST101), that is a new azaindolizinone derivative without inhibitory action on acetylcholine esterase (AChE). Interestingly, ZSET1446 improved learning and memory by potentiating nicotine-induced ACh release in the hippocampus of amyloid-beta infused rats. In addition, ZSET1446 restored OBX-induced cognitive deficits in mice. Furthermore, chronic ZSET1446 administration significantly rescues decreased neuronal precursor cell proliferation seen in the dentate gyrus of OBX mice. Consistent with enhanced neurogenesis, chronic ZSET1446 administration improved depressive behavior assessed using the tail suspension test in OBX mice. Protein kinase B (Akt) and extracellular signal-regulated kinase pathways likely mediate ZSET1446-induced neurogenesis. These results suggest that ZSET1446 action via stimulation of the cholinergic system elicits improvement of the depression and cognitive impairment observed in Alz disease patients.
Neurochemical Mechanisms of a Novel Alzheimer′s Disease Therapeutics on Improvement of Cognition and Depressive Behavior

Norifumi Shioda,Yui Yamamoto,Feng Han,Shigeki Moriguchi,Kohji Fukunaga

DOI: https://doi.org/10.1002/chin.201143267

2011-01-01

ChemInform

Abstract:Loss of cholinergic neurons and/or dysfunction of the glutamatergic system in the central nervous system cause learning impairment in experimental Alzheimer's (Alz) disease animals and Alz patients. Furthermore, the impaired cholinergic system is likely implicated in depressive behaviors in Alz patients. Neurogenesis persistently occurs in the forebrain subventricular zone (SVZ) and hippocampal subgranular zone (SGZ) in rodent and human brains. Notably, impaired neurogenesis in those regions is implicated not only in memory deficits but also in depressive behaviors. We have recently found that olfactory bulbectomized (OBX) mice reveal memory impairment and depressive behaviors. Using this attractive OBX mice model, we discovered a novel cognitive enhancer, spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446/ST101), that is a new azaindolizinone derivative without inhibitory action on acetylcholine esterase (AChE). Interestingly, ZSET1446 improved learning and memory by potentiating nicotine-induced ACh release in the hippocampus of amyloid-beta infused rats. In addition, ZSET1446 restored OBX-induced cognitive deficits in mice. Furthermore, chronic ZSET1446 administration significantly rescues decreased neuronal precursor cell proliferation seen in the dentate gyrus of OBX mice. Consistent with enhanced neurogenesis, chronic ZSET1446 administration improved depressive behavior assessed using the tail suspension test in OBX mice. Protein kinase B (Akt) and extracellular signal-regulated kinase pathways likely mediate ZSET1446-induced neurogenesis. These results suggest that ZSET1446 action via stimulation of the cholinergic system elicits improvement of the depression and cognitive impairment observed in Alz disease patients.
[What is the value of Goetze's wire cerclage in treating torsion fractures of the lower leg?].

J. Rütt,E. Beck

1985-07-01

Der Unfallchirurg

Abstract:
Determination of isotope ratios in human tissues enriched with zinc stable isotope tracers using inductively coupled plasma-mass spectrometry (ICP-MS)

J. Friel,H. Longerich,S. Jackson

DOI: https://doi.org/10.1007/BF02783788

IF: 4.081

1993-05-01

Biological Trace Element Research

Abstract:
Cognitive and Histopathological Alterations in Rat Models of Early- and Late-Phase Memory Dysfunction: Effects of Sigma-1 Receptor Activation

Anna Kostenko,Orazio Prezzavento,Gioacchino de Leo,David D'Arco,Rosario Gulino,Antonella Caccamo,Giampiero Leanza

DOI: https://doi.org/10.3233/jad-240618

2024-09-04

Journal of Alzheimer s Disease

Abstract:Background: Sigma-1 receptors are highly expressed in brain areas related to cognitive function and are a promising target for anti-amnesic treatments. We previously showed that activation of sigma-1 receptors by the selective agonist compound methyl(1 R,2 S/1 S,2 R)-2-[4-hydroxy-4-phenylpiperidin-1-yl)methyl]-1-(4-methylphenyl) cyclopropane carboxylate [(±)-PPCC] promotes a remarkable recovery in rat models of memory loss associated to cholinergic dysfunction. Objective: In this study, we sought to assess the role of (±)-PPCC on working memory deficits caused by noradrenergic depletion. Methods: Animals with a mild or severe working memory deficits associated to varying degrees of noradrenergic neuronal depletion were treated with the sigma-1 agonist just prior to the beginning of each behavioral testing session. Results: While (±)-PPCC alone at a dose of 1 mg/kg/day failed to affect working memory in lesioned animals, its association with the α2 adrenergic receptor agonist clonidine, completely blocked noradrenaline release, significantly improving rat performance. This effect, distinct from noradrenaline activity, is likely to result from a direct action of the (±)-PPCC compound onto sigma-1 receptors, as pre-treatment with the selective sigma-1 receptor antagonist BD-1047 reversed the improved working memory performance. Despite such clear functional effects, the treatment did not affect noradrenergic neuron survival or terminal fiber proliferation. Conclusions: Future studies are thus necessary to address the effects of long-lasting (±)-PPCC treatment, with or without clonidine, on cognitive abilities and Alzheimer's disease-like histopathology. Considering the already established involvement of sigma-1 receptors in endogenous cell plasticity mechanisms, their activation by selective agonist compounds holds promises as possibly positive contributor to disease-modifying events in neurodegenerative diseases.

neurosciences
A Comparative Study of the Impact of NO-Related Agents on MK-801- or Scopolamine-Induced Cognitive Impairments in the Morris Water Maze

Paulina Cieślik,Magdalena Borska,Joanna Monika Wierońska

DOI: https://doi.org/10.3390/brainsci13030410

IF: 3.333

2023-02-28

Brain Sciences

Abstract:Learning and memory deficits accompany numerous brain dysfunctions, including schizophrenia and Alzheimer's disease (AD), and many studies point to the role of nitric oxide (NO) in these processes. The present investigations constitute the follow-up of our previous research, in which we investigated the activity of NO releasers and a selective inhibitor of neuronal NO synthase (nNOS) to prevent short-term memory deficits in novel object recognition and T-maze. Here, the ability of the compounds to prevent the induction of long-term memory deficits by MK-801 or scopolamine administration was investigated. The Morris Water Maze test, a reliable and valid test of spatial learning and memory, was used, in which escape latency in the acquisition phase and nine different parameters in the retention phase were measured. A fast NO releaser (spermine NONOate), a slow NO releaser (DETA NONOate), and a nNOS inhibitor, N(ω)-propyl-L-arginine (NPLA), were used. The compounds were administered i.p. at a dose range of 0.05–0.5 mg/kg. All compounds prevented learning deficits in the acquisition phase and reversed reference memory deficits in the retention phase of the scopolamine-treated mice. Spermine NONOate was the least effective. In contrast, the drugs poorly antagonised MK-801-induced deficits, and only the administration of DETA NONOate induced some improvements in the retention trial.

neurosciences
Mapping Wetlands from Their Spectral Properties Recorded by ERTS System

L. Bartolucci,R. M. Hoffer,S. G. Luther

Abstract:LARS/Purdue University West Lafayette, Indiana The use of computer-aided analysis techniques (CAAT) and multispectral scanner data from aircraft and satellite altitudes has shown considerable promise for water resources applications. Two areas of particular interest are: (1) temperature mapping of surface water to study the environmental impact of thermal effluents and (2) snow-cover mapping in mountainous regions to improve water yield predictions. The conventional LARSYS classifier has proven to be inadequate for these purpose~ Therefore, a layered classification approach was utilized to overcome the lirnit~ tions of the conventional LARSYS classifier. If the primary objective is to map the thermal characteristics of water bodies only, the ability to discriminate between water and all other earth surface features becomes important. In some cases however, the radiant temperatures given off by vegetation and soils are the same as those given off by the water bodies. Therefore, such discrimination cannot be accomplished using only a thermal band. A new procedure involving a layered classification was developed to separate water from all other caver types by utilizing a near or middle infrared band, and then to calibrate the thermal data of only those elements classified as water. Thus, the result is a temperature map of water only. In a second water reSOurces study, tne areal extent of snow cover in a mountainous region of Colorado was mapped by using LANDSAT-1 and SKYLAB S-192 multispectral data. The results indicated that it was not possible to obtain a multispectral classification of the snow covered area through the conventional LARSYS classifier because several of the wavelength bands on the LANDSAT and SKYLAS data saturated whenever the scanner was collecting data over the snowpack. The saturated detectors produced a singular covariance matrix which precluded classification. However, 2B-38 a layered classifier approach was developed which could be effectively utilized to obtain a snow cover map. MAPPING WETLANDS FROM THEIR SPECTRAL PROPERTIES RECORDED BY ERTS SYSTEM S. J. Kristof, R. A. Weismiller
Kinetics, mechanism, and inhibition of monoamine oxidase

Rona R. Ramsay,Alen Albreht

DOI: https://doi.org/10.1007/s00702-018-1861-9

IF: 3.85

2018-03-07

Journal of Neural Transmission

Abstract:Monoamine oxidases (MAOs) catalyse the oxidation of neurotransmitter amines and a wide variety of primary, secondary and tertiary amine xenobiotics, including therapeutic drugs. While inhibition of MAO activity in the periphery removes protection from biogenic amines and so is undesirable, inhibition in the brain gives vital antidepressant and behavioural advantages that make MAO a major pharmaceutical target for inhibitor design. In neurodegenerative diseases, MAO inhibitors can help to maintain neurotransmitter levels, making it a common feature in novel multi-target combinations designed to combat Alzheimer’s disease, albeit not yet proven clinically. Vital information for inhibitor design comes from an understanding of the structure, mechanism, and kinetics of the catalyst. This review will summarize the kinetic behaviour of MAO A and B and the kinetic evaluation of reversible inhibitors that transiently decrease catalysis. Kinetic parameters and crystal structures have enabled computational approaches to ligand discovery and validation of hits by docking. Kinetics and a wide variety of substrates and inhibitors along with theoretical modelling have also contributed to proposed schemes for the still debated chemical mechanism of amine oxidation. However, most of the marketed MAO drugs are long-lasting irreversible inactivators. The mechanism of irreversible inhibition by hydrazine, cyclopropylamine, and propargylamine drugs will be discussed. The article finishes with some examples of the propargylamine moiety in multi-target ligand design to combat neurodegeneration.

neurosciences,clinical neurology
Synergistic effect between prelimbic 5-HT3 and CB1 receptors on memory consolidation deficit in adult male Sprague-Dawley rats: An isobologram analysis

N Ahmadi-Mahmoodabadi,M Nasehi,M Emam Ghoreishi,M-R Zarrindast

DOI: https://doi.org/10.1016/j.neuroscience.2015.12.010

IF: 3.708

2016-03-11

Neuroscience

Abstract:The serotonergic system has often been defined as a neuromodulator system, and is specifically involved in learning and memory via its various receptors. Serotonin is involved in many of the same processes affected by cannabinoids. The present study investigated the influence of bilateral post-training intra-prelimbic (PL) administrations of serotonergic 5-hydroxytryptamine type-3 (5-HT3) receptor agents on arachidonylcyclopropylamide (ACPA) (cannabinoid CB1 receptor agonist)-induced amnesia, using the step-through inhibitory avoidance (IA) task to assess memory in adult male Sprague-Dawley rats. The results indicated that sole intra-PL microinjection of ACPA (0.1 and 0.5 μg/rat) and 5-HT3 serotonin receptor agonist (m-Chlorophenylbiguanide hydrochloride, m-CPBG; 0.001, 0.01 and 0.1 μg/rat) impaired, whereas Y-25130 (a selective 5-HT3 serotonin receptor antagonist; 0.001 and 0.01 and 0.1 μg/rat) did not alter IA memory consolidation, by itself. Moreover, intra-PL administration of subthreshold dose of m-CPBG (0.0005 μg/rat) potentiated, while Y-25130 (0. 1 μg/rat) restored ACPA-induced memory consolidation deficit. The isobologram analysis showed that there is a synergistic effect between ACPA and m-CPBG on memory consolidation deficit. These findings suggest that 5-HT3 receptor mechanism(s), at least partly, play(s) a role in modulating the effect of ACPA on memory consolidation in the PL area.
Suppression of EBV release from irradiated B lymphoblastoid cell-lines: superior activity of ganciclovir compared with acyclovir.

C. Keever-Taylor,B. Behn,S. Konings,R. Orentas,B. Davies,D. Margolis

DOI: https://doi.org/10.1080/14653240310002243

IF: 6.196

Cytotherapy

Abstract:BACKGROUND B lymphoblastoid cell-lines (BLCL), generated by exposure of PBMC to a laboratory strain of EBV, are commonly utilized in the preparation of T cells used for immunotherapy. Although most B cells are latently infected, BLCL contain a subset of cells that harbor infectious virus, which could be released into the infusion product during preparation. To reduce this known risk, laboratories have pretreated BLCL for > or = 14 days with 100 microM acyclovir (ACV), an inhibitor of viral DNA polymerase, prior to use. We tested the effectiveness of ACV in preventing the release of infectious virus from irradiated fresh and previously frozen BLCL, and compared its effects with those of ganciclovir (GCV). METHODS BLCL were grown for 14 days in medium containing various doses of ACV or GCV, washed, irradiated, and tested for the presence of infectious virus in co-culture assays with cord blood mononuclear cells(CBMC) (21 CBMC to BLCL). B-cell transformation was assessed at 3-4 weeks of culture. RESULTS Both fresh and previously frozen BLCL released infectious virus, which transformed nearly all (92%) of CBMC co-cultures (n = 52). Transformation was not prevented by treatment with 100 microM ACV (88%, n = 52). Increasing the ACV dose to 200 microM (or 50 microg/mL) still allowed transformation in 4/9 (44%) cultures, while this and higher doses severely reduced the proliferation rate of the BLCL during ACV exposure. Infectious virus release was detectable within 1 day of ACV removal and BLCL irradiation. In contrast, GCV was able to prevent infectious virus release in 12/12 co-cultures at a concentration (15 microM) that only modestly reduced BLCL growth. DISCUSSION These results indicate that GCV is more effective at preventing release of infectious EBV from irradiated BLCL than ACV at concentrations that do not severely inhibit B-cell growth.
Tissue distribution, characterization and in vitro inhibition of B-esterases in the earwig Forficula auricularia.

Laure Malagnoux,Y. Capowiez,M. Rault

DOI: https://doi.org/10.1016/j.chemosphere.2014.05.003

IF: 8.8

2014-10-01

Chemosphere

Abstract:
Effect of echinacoside on monoamine neurotransmitters in hippocampus and cortex of rats with Alzheimer′s disease

Hui DING,Hong CHEN,Yong JIANG,Peng-fei TU,Jing-yi MA,Wan-xin ZHANG

DOI: https://doi.org/10.3969/j.issn.1001-1978.2014.11.017

2014-01-01

Abstract:Aim To investigate the influence of echi-nacoside ( ECH ) on monoaminergic neurotransmitter extracellular of the hippocampus and cerebral cortex in rat model of Alzheimer′s disease ( AD) , and ultimately to provide a theoretical basis for ECH′s improving the ability of learning and memory. Methods 60 male SD rats were randomly divided into 6 groups with 10 rats in each group : sham operation group, model, ECH groups of low, medium and high doses (10, 20, 40μg ·g-1 ·d-1 ) , and Hup A ( Huperzine A, 0. 02 μg· g-1·d-1) group. The AD rat model was established by abdominal cavity injection with D-galactose and uni-laterally injected with amyloid beta-protein fragment 25-35 ( Aβ25-35 ) into the right hippocampus. Morris wa-ter maze test was used to study the animals′ ability of spatial learning and memory. The synchronous dual-probe dual-channel brain microdialysis sampling tech-nology was applied to collect dialysates from different encephalic areas continuously, and combined with HPLC electrochemical detection were used to measure the extracellular levels of norepinephrine ( NE) , dopa-mine (DA), 5-serotonin (5-HT). Results 1. Com-pared with the sham operation group, the mean escape latency of the model group was significantly prolonged ( P<0. 05 ) , and the time that rats were in the plat-form quadrant was significantly shortened ( P<0. 05 );on the contrary, compared with the model group, the mean escape latency of ECH groups were significantly shortened ( P<0. 05 ) , and the time that rats were in the platform quadrant was significantly extended ( P<0. 05). 2. Compared with the sham operation group, the contents of NE,DA and 5-HT were significantly de-creased in the model group ( P <0. 05 ) . However, compared with the model group , ECH could improve the concentrations of NE, DA, 5-HT in the hippocam-pus and cerebral cortex, and these monoamine levels of the brain regions were restored to near control. Con-clusion ECH can effectively improve the ability of learning and memory of rats with AD, giving a rise to the monoamine neurotransmitter both in hippocampus and cortex, exerting a positive effect on treatment of cognitive dysfunction . The ECH low dose group is sig-nificantly lower than the ECH groups of medium and high doses and Hup A group in improving the ability of learning and memory.
Methylphenidate Enhances Memory Consolidation and Amplifies Long-Term Potentiation: Differential Involvement of the Prefrontal Dopamine Receptor and Norepinephrine Receptor

Xue-Han Zhang,Shu-Su Liu,Feng Yi,Hou-Cheng Zhou

DOI: https://doi.org/10.1254/jpssuppl.wcp2018.0_po1-1-13

2018-01-01

Proceedings for Annual Meeting of The Japanese Pharmacological Society

Abstract:Methylphenidate (MPH; Ritalin) is the most commonly prescribed treatment for attention-deficit hyperactive disorder (ADHD). MPH causes behavioral and academic performance improvements in children with ADHD, as well as in healthy subjects. MPH has become one of the most widely abused drugs on college campuses. Previously, improvements were considered to be associated with the increased attention. In this study, we examined the effects of MPH on memory storage through administrating MPH after behavioral training, which eliminating the effect of increased attention on memory acquisition, and indicated a direct role of MPH on memory storage. Additionally, this MPH enhancement arose from action via norepinephrine beta-1receptor, but not dopamine D1/D5 receptor. Electrophysiological recordings in vitro showed that MPH enhanced synaptic plasticity by amplifying the magnitude of long-term potentiation (LTP), and this MPH enhancement involved action via both beta-1receptor and D1/D5 receptor. While there was differential role between dopamine and norepinephrine receptor, D1/D5 receptor was more response for the induction of LTP through suppressing GABAergic input.
Influence of acute or chronic calcium channel antagonists on the acquisition and consolidation of memory and nicotine-induced cognitive effects in mice

Grazyna Biala,Marta Kruk-Slomka,Krzysztof Jozwiak

DOI: https://doi.org/10.1007/s00210-013-0866-z

Abstract:Nicotinic cholinergic receptors (nAChRs) form a heterogeneous family of ligand-gated ion channels found in the nervous system. The main objective of our research was to investigate the interaction between cholinergic nicotinic system and calcium homeostasis in cognitive processes using the modified elevated plus maze memory model in mice. The time each mouse took to move from the open arm to either of the enclosed arms on the retention trial (transfer latency, TL2) was used as an index of memory. Our results showed that a single injection of nicotine (0.035 and 0.175 mg/kg) shortened TL2 values, improving memory-related processes. Similarly, L-type calcium channel antagonists (CCAs), i.e., flunarizine, verapamil, amlodipine, nimodipine, nifedipine, and nicardipine (at the range of dose 5-20 mg/kg) administered before or after training, decreased TL2 value improving memory acquisition and/or consolidation. Interestingly, at the subthresold doses, flunarizine, nicardipine, amlodipine, verapamil, and bupropion, a nAChR antagonist, significantly reversed the nicotine improvement of memory acquisition, while flunarizine, verapamil, and bupropion attenuated the improvement of memory consolidation provoked by an acute injection of nicotine (0.035 mg/kg, s.c.). After subchronic administration (14 days, i.p.) of verapamil and amlodipine, two CCAs with the highest affinity for nAChRs, only verapamil (5 mg/kg) impaired memory acquisition and consolidation while both verapamil and amlodipine, at the subthresold, ineffective dose (2.5 mg/kg), significantly reversed the improvement of memory provoked by an acute injection of nicotine (0.035 mg/kg, s.c.). Our findings can be useful to better understand the interaction between cholinergic nicotinic receptors and calcium-related mechanisms in memory-related processes.
The memory ameliorating effects of novel N-benzyl pyridine-2-one derivatives on scopolamine-induced cognitive deficits in mice

Swati Pant,Mohan Gupta,Tulika Anthwal,Monika Chauhan,Sumitra Nain

DOI: https://doi.org/10.1186/s42826-023-00187-y

2024-03-11

Laboratory Animal Research

Abstract:Abstract Background Alzheimer's disease (AD), the most common form of progressive dementia in the elderly, is a chronic neurological disorder that decreases cognitive ability. Although the underlying cause of AD is yet unknown, oxidative stress and brain acetylcholine shortage are the key pathogenic causes. Results The current study shows that these derivatives have the potential to improve memory in mice by inhibiting scopolamine-induced acetylcholinesterase activity, oxidative and nitrosative stress, and improving locomotor activity and muscle grip strength in the rota rod test. When compared to the illness control, the memory-enhancing potential of novel N -benzyl pyridine-2-one derivatives was highly significant (P < 0.0001). Conclusions The observed memory ameliorating effect of novel N -benzyl pyridine-2-one makes them as a a good choice for treatment of individuals with cognitive impairment. Graphical abstract
A Distinct Role for Norepinephrine in Memory Retrieval

Charles F Murchison,Xiao-Yan Zhang,Wei-Ping Zhang,Ming Ouyang,Anee Lee,Steven A Thomas

DOI: https://doi.org/10.1016/S0092-8674(04)00259-4

IF: 64.5

2004-01-01

Cell

Abstract:A role for norepinephrine in learning and memory has been elusive and controversial. A longstanding hypothesis states that the adrenergic nervous system mediates enhanced memory consolidation of emotional events. We tested this hypothesis in several learning tasks using mutant mice conditionally lacking norepinephrine and epinephrine, as well as control mice and rats treated with adrenergic receptor agonists and antagonists. We find that adrenergic signaling is critical for the retrieval of intermediate-term contextual and spatial memories, but is not necessary for the retrieval or consolidation of emotional memories in general. The role of norepinephrine in retrieval requires signaling through the β1-adrenergic receptor in the hippocampus. The results demonstrate that mechanisms of memory retrieval can vary over time and can be different from those required for acquisition or consolidation. These findings may be relevant to symptoms in several neuropsychiatric disorders as well as the treatment of cardiac failure with β blockers.
Effects of acute administration of donepezil or memantine on sleep-deprivation-induced spatial memory deficit in young and aged non-human primate grey mouse lemurs (Microcebus murinus)

Anisur Rahman,Yves Lamberty,Esther Schenker,Massimo Cella,Solène Languille,Régis Bordet,Jill Richardson,Fabien Pifferi,Fabienne Aujard

DOI: https://doi.org/10.1371/journal.pone.0184822

IF: 3.7

2017-09-18

PLoS ONE

Abstract:The development of novel therapeutics to prevent cognitive decline of Alzheimer's disease (AD) is facing paramount difficulties since the translational efficacy of rodent models did not resulted in better clinical results. Currently approved treatments, including the acetylcholinesterase inhibitor donepezil (DON) and the N-methyl-D-aspartate antagonist memantine (MEM) provide marginal therapeutic benefits to AD patients. There is an urgent need to develop a predictive animal model that is phylogenetically proximal to humans to achieve better translation. The non-human primate grey mouse lemur (Microcebus murinus) is increasingly used in aging research, but there is no published results related to the impact of known pharmacological treatments on age-related cognitive impairment observed in this primate. In the present study we investigated the effects of DON and MEM on sleep-deprivation (SD)-induced memory impairment in young and aged male mouse lemurs. In particular, spatial memory impairment was evaluated using a circular platform task after 8 h of total SD. Acute single doses of DON or MEM (0.1 and 1mg/kg) or vehicle were administered intraperitoneally 3 h before the cognitive task during the SD procedure. Results indicated that both doses of DON were able to prevent the SD-induced deficits in retrieval of spatial memory as compared to vehicle-treated animals, both in young and aged animals Likewise, MEM show a similar profile at 1 mg/kg but not at 0.1mg/kg. Taken together, these results indicate that two widely used drugs for mitigating cognitive deficits in AD were partially effective in sleep deprived mouse lemurs, which further support the translational potential of this animal model. Our findings demonstrate the utility of this primate model for further testing cognitive enhancing drugs in development for AD or other neuropsychiatric conditions.

multidisciplinary sciences
Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism

Sara Martínez-Torres,Araceli Bergadà-Martínez,Jorge E Ortega,Lorena Galera-López,Arnau Hervera,Lucía de Los Reyes-Ramírez,Antonio Ortega-Álvaro,Floortje Remmers,Emma Muñoz-Moreno,Guadalupe Soria,José Antonio Del Río,Beat Lutz,Jose Ángel Ruíz-Ortega,J Javier Meana,Rafael Maldonado,Andrés Ozaita

DOI: https://doi.org/10.1038/s41386-022-01436-9

Neuropsychopharmacology

Abstract:Peripheral inputs continuously shape brain function and can influence memory acquisition, but the underlying mechanisms have not been fully understood. Cannabinoid type-1 receptor (CB1R) is a well-recognized player in memory performance, and its systemic modulation significantly influences memory function. By assessing low arousal/non-emotional recognition memory in mice, we found a relevant role of peripheral CB1R in memory persistence. Indeed, the peripherally-restricted CB1R specific antagonist AM6545 showed significant mnemonic effects that were occluded in adrenalectomized mice, and after peripheral adrenergic blockade. AM6545 also transiently impaired contextual fear memory extinction. Vagus nerve chemogenetic inhibition reduced AM6545-induced mnemonic effect. Genetic CB1R deletion in dopamine β-hydroxylase-expressing cells enhanced recognition memory persistence. These observations support a role of peripheral CB1R modulating adrenergic tone relevant for cognition. Furthermore, AM6545 acutely improved brain connectivity and enhanced extracellular hippocampal norepinephrine. In agreement, intra-hippocampal β-adrenergic blockade prevented AM6545 mnemonic effects. Altogether, we disclose a novel CB1R-dependent peripheral mechanism with implications relevant for lengthening the duration of non-emotional memory.

Similar effects of a monoamine oxidase inhibitor and a sympathomimetic amine on memory formation

Psychotomimetic Effects of Different Doses of MK-801 and the Underlying Mechanisms in a Selective Memory Impairment Model

Evaluation of the role of monoaminergic and nonmonoaminergic systems in the psychotropic effects of morin in mice: an interaction study with receptor blockers

Neurochemical mechanisms of a novel Alzheimer's disease therapeutics on improvement of cognition and depressive behavior]

Neurochemical Mechanisms of a Novel Alzheimer′s Disease Therapeutics on Improvement of Cognition and Depressive Behavior

[What is the value of Goetze's wire cerclage in treating torsion fractures of the lower leg?].

Determination of isotope ratios in human tissues enriched with zinc stable isotope tracers using inductively coupled plasma-mass spectrometry (ICP-MS)

Cognitive and Histopathological Alterations in Rat Models of Early- and Late-Phase Memory Dysfunction: Effects of Sigma-1 Receptor Activation

A Comparative Study of the Impact of NO-Related Agents on MK-801- or Scopolamine-Induced Cognitive Impairments in the Morris Water Maze

Mapping Wetlands from Their Spectral Properties Recorded by ERTS System

Kinetics, mechanism, and inhibition of monoamine oxidase

Synergistic effect between prelimbic 5-HT3 and CB1 receptors on memory consolidation deficit in adult male Sprague-Dawley rats: An isobologram analysis

Suppression of EBV release from irradiated B lymphoblastoid cell-lines: superior activity of ganciclovir compared with acyclovir.

Tissue distribution, characterization and in vitro inhibition of B-esterases in the earwig Forficula auricularia.

Effect of echinacoside on monoamine neurotransmitters in hippocampus and cortex of rats with Alzheimer′s disease

Methylphenidate Enhances Memory Consolidation and Amplifies Long-Term Potentiation: Differential Involvement of the Prefrontal Dopamine Receptor and Norepinephrine Receptor

Influence of acute or chronic calcium channel antagonists on the acquisition and consolidation of memory and nicotine-induced cognitive effects in mice

The memory ameliorating effects of novel N-benzyl pyridine-2-one derivatives on scopolamine-induced cognitive deficits in mice

A Distinct Role for Norepinephrine in Memory Retrieval

Effects of acute administration of donepezil or memantine on sleep-deprivation-induced spatial memory deficit in young and aged non-human primate grey mouse lemurs (Microcebus murinus)

Peripheral CB1 receptor blockade acts as a memory enhancer through a noradrenergic mechanism